1-BETA-(1,3-DIHYDRO-2-TOSYL-2H-INDOL-5-YL)-1,2-DIDEOXY-3,5-DI-O-(4-TOLUOYL)-D-RIBOFURANOSIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | CjTMDU9hbH0 |
|---|---|
| InChI | InChI=1S/C36H35NO7S/c1-23-4-10-26(11-5-23)35(38)42-22-34-33(44-36(39)27-12-6-24(2)7-13-27)19-32(43-34)28-14-15-29-20-37(21-30(29)18-28)45(40,41)31-16-8-25(3)9-17-31/h4-18,32-34H,19-22H2,1-3H3/t32-,33+,34-/m1/s1 |
| InChIKey | ORLSDFVPJLMYMZ-OUYGKKDFSA-N |
| Mol Weight | 625.7 g/mol |
| Molecular Formula | C36H35NO7S |
| Exact Mass | 625.213424 g/mol |
| Enantiomer InChIKey | ORLSDFVPJLMYMZ-GMTSZFNJSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | C6D6 |
1-BETA-[2,2-BIS-(ETHOXYCARBONYL)-1,3-DIHYDRO-2H-INDEN-5-YL]-1,2-DIDEOXY-3,5-DI-O-(4-TOLUOYL)]-D-RIBOFURANOSIDE
HNNXWQNWNACXEE-HKBOAZHASA-N
1-[2-DEOXY-3,5-DI-O,O-(4-METHYLBENZOYL)-ALPHA-D-RIBOFURANOSYL]-2-(4-CHLOROPHENYLAMINO)-4-PYRIMIDINONE
1-[2-DEOXY-3,5-DI-O,O-(4-METHYLBENZOYL)-BETA-D-RIBOFURANOSYL]-2-(4-CHLOROPHENYLAMINO)-4-PYRIMIDINONE
3-{7-[(4-methylphenyl)sulfonyl]-7,8-dihydto-6H-furo[2,3-e]isoindol-2-yl)propyl 4-methylbenzenesulfonate
.alpha.-D-Fructopyranoside, methyl, tetrakis(4-nitrobenzoate)
.beta.-D-Fructopyranoside, methyl, tetrakis(4-nitrobenzoate)
1-[3,5-BIS-O-(PARA-NITROBENZOYL)-2-DEOXY-ALPHA-D-RIBOFURANOSYL]-5-(TRIFLUOROMETHYL)-URACIL
1-[3,5-BIS-O-(PARA-NITROBENZOYL)-2-DEOXY-BETA-D-RIBOFURANOSYL]-5-(TRIFLUOROMETHYL)-URACIL
S-PARA-TOLYL 2,3,4,6-TETRA-O-BENZOYL-1-THIO-BETA-D-GALACTOPYRANOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of C-Aryldeoxyribosides by [2 + 2 + 2]-Cyclotrimerization Catalyzed by Rh, Ni, Co, and Ru Complexes | Organic Letters | 2006 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.